Trial Profile
Compassionate use study of MTX110 in Diffuse Intrinsic Pontine Glioma (DIPG) patients
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 22 Sep 2016
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary)
- Indications Diffuse intrinsic pontine glioma
- Focus Expanded access; Therapeutic Use
- 22 Sep 2016 New trial record